• 0
Shop Products $

ADAM17 fluorometric drug discovery kit 96 wells. ADAM17 fluorometric drug discovery kit, Contains: ADAM17 enzyme, Substrate (Mca-PLAQAV-Dpa-RSSSR-NH2), DMSO, CALIBRATION STANDARD, control inhibitor (GM6001), assay buffer, Applications: Fluorescent detection, HTS Activity assay, Size: 96 wells

BML-281 HDAC6 inhibitor 5 mg. BML-281 HDAC6 inhibitor C22H30N4O6, proliferation of pancreatic cancer cell linesMolecular Weight: 446.5, Cas No: 1045792-66-2, Purity: /= 98%, Appearance: Off-white solid, Synonyms: N-Hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-3-isoxazolecarboxamido], Size: 5 mg

Tubacin HDAC inhibitor inhibitor 500 ug. Tubacin HDAC inhibitor inhibitorC41H43N3O7S, MW: 721.9, Cas No: 537049-40-4, Purity: /= 96%, Appearance:White solid, Source: Synthetic, Synonyms: N-(4-{(2R,4R,6S)-4-{[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanyl]methyl}-6-[4-(hydroxymethyl)phenyl], Size: 500 ug

Niltubacin inhibitor 100 ug. Niltubacin inhibitor, Formula: C41H42N2O7S, MW: 706.9, Purity: /= 98%, Appearance: White solid, Source: Synthetic, Synonyms: 7-(4-((2R,4R,6S)-4-((4,5-dipenyloxazol-2-ylthio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-dioxan-2-yl)phenylcarbamoyl)heptanoic acid, Size: 100 ug

Niltubacin inhibitor 500 ug. Niltubacin inhibitor, Formula: C41H42N2O7S, MW: 706.9, Purity: /= 98%, Appearance: White solid, Source: Synthetic, Synonyms: 7-(4-((2R,4R,6S)-4-((4,5-dipenyloxazol-2-ylthio)methyl)-6-(4-(hydroxymethyl)phenyl)-1,3-dioxan-2-yl)phenylcarbamoyl)heptanoic acid, Size: 500 ug

12(S)-Hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid (HETE) Ultra-pure 50 ug. 12(S)-Hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid (HETE)Ultra-pure, Formula: C20H32O3, Molecular Weight: 320.5, Cas No: 54397-83-0, Purity: /= 98%, Appearance: Liquid, Formulation: Liquid, Synonyms: 12(S)-HETE, Size: 50 ug

Olpidem Metabolite I Major metabolite of zolpidem 5 mg. Olpidem Metabolite I Major metabolite of zolpidem, Formula: C19H19N3O3, MW: 337.37, Cas No: 109461-65-6, Purity: /= 98%, Synonyms: 4-[3-[2-(Dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl] benzoic acid, Zolpidem, Size: 5 mg

Zolpidem Metabolite I Major metabolite of zolpidem 5 mg. Zolpidem Metabolite I Major metabolite of zolpidem, Formula: C19H19N3O3, MW: 337.37, Cas No: 109461-65-6, Purity: /= 98%, Synonyms: 4-[3-[2-(Dimethylamino)-2-oxoethyl]-6-methylimidazo[1,2-a]pyridin-2-yl] benzoic acid, Zolpidem, Size: 5 mg

FLUOR DE LYS-Succinyl, Desuccinylase substrate 50 ul. FLUOR DE LYS-Succinyl, Desuccinylase substrate, Source: SyntheticConcentration: 5 mM, Purity: /= 95%, Formulation: Liquid, Solubility: Solution in DMSOFormulation: Lyophilized, Sterile, Absorbance maximum: 350-380nm, Size: 50 ul

FLUOR DE LYS-Succinyl Green, Desuccinylase substrate inhibitor 50 ul. FLUOR DE LYS-Succinyl Green, Desuccinylase substrate inhibitor, Source: SyntheticConcentration: 5 mM, Purity: /= 95%, Formulation: Liquid, Solubility: Solution in DMSOFormulation: Synthetic, Absorbance: 350-380nm, Size: 50 ul

N-Palmitoyl phosphatidylethanolamine 1 mg. N-Palmitoyl phosphatidylethanolamine, Formula: C53H104NO9P, MW: 930.4, CAS: 108321-22-8, Purity: /= 98% (TLC), Appearance: White solid, Synonyms: C16:0 NAPE, NPPE, significantly reduced food intake in a dose-dependent, Storage: -20 deg C, Size: 1 mg

PNU-74654Catenin blocker 5 mg. PNU-74654Catenin blocker C19H16N2O3, Molecular Weight: 320.3, Cas No: 113906-27-7, Purity: greater than or equal to 98%, Appearance: Off-white solid, Solubility: Soluble in DMSO, Synonyms: 2-Phenoxybenzoic acid [(5-methyl-2-furanyl)methylene]hydrazide, Size: 5 mg

PNU-74654Catenin blocker 25 mg. PNU-74654Catenin blocker C19H16N2O3, Molecular Weight: 320.3, Cas No: 113906-27-7, Purity: greater than or equal to 98%, Appearance: Off-white solid, Solubility: Soluble in DMSO, Synonyms: 2-Phenoxybenzoic acid [(5-methyl-2-furanyl)methylene]hydrazide, Size: 25 mg

IM-12 inhibitor 5 mg. IM-12 inhibitor C22H20FN3O2, Molecular Weight: 377.4, Cas No: 1129669-05-1, Purity: greater than or equal to 98%, Appearance: Orange solid, Synonyms: 3-(4-Fluorophenylethylamino)-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, Storage: -20 deg C, Size: 5 mg

IM-12 inhibitor 25 mg. IM-12 inhibitor C22H20FN3O2, Molecular Weight: 377.4, Cas No: 1129669-05-1, Purity: greater than or equal to 98%, Appearance: Orange solid, Synonyms: 3-(4-Fluorophenylethylamino)-1-methyl-4-(2-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, Storage: -20 deg C, Size: 25 mg

BML-284 Wnt activator 5 mg. BML-284 Wnt activatorC19H18N4O3, Molecular Weight: 350.4, Cas No: 853220-52-7, Purity: /= 98%, Appearance: Off-white solid, Solubility: Soluble in DMSO, Synonyms: 2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine, Storage: -20 deg C, Size: 5 mg

BML-284 Wnt activator 25 mg. BML-284 Wnt activatorC19H18N4O3, Molecular Weight: 350.4, Cas No: 853220-52-7, Purity: /= 98%, Appearance: Off-white solid, Solubility: Soluble in DMSO, Synonyms: 2-Amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine, Storage: -20 deg C, Size: 25 mg

WAY-262611DKK1 inhibitor 5 mg. WAY-262611DKK1 inhibitor C20H22N4, Molecular Weight: 318.4, Purity: greater than or equal to 97%, Appearance: Off-white solid, Synonyms: (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine, Storage: -20 deg C, Size: 5 mg

WAY-262611 DKK1 inhibitor 25 mg. WAY-262611 DKK1 inhibitor C20H22N4, Molecular Weight: 318.4, Purity: greater than or equal to 97%, Appearance: Off-white solid, Synonyms: (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine, Storage: -20 deg C, Size: 25 mg

FH535 nhibits the recruitment of the co-activators B-catenin and GRIP1 5 mg. FH535 nhibits the recruitment of the co-activators B-catenin and GRIP1 C13H10Cl2N2O4S, MW: 361.2, Cas No: 108409-83-2, Purity: /= 98%, Appearance: Yellow solid, Synonyms: N-(2-Methyl-4-nitrophenyl), Size: 5 mg

Adiporon 5 mg. Adiporon, Novel and orally active adiponectin receptor, Formula: C27H28N2O3, Molecular Weight: 428.52, Cas No: 924416-43-3, Purity: greater than or equal to 98% (HPLC), Solubility: Soluble in DMSO, Synonyms: 2-(4-benzoylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide, Size: 5 mg

Adiporon 10 mg. Adiporon, Novel and orally active adiponectin receptor, Formula: C27H28N2O3, Molecular Weight: 428.52, Cas No: 924416-43-3, Purity: greater than or equal to 98% (HPLC), Solubility: Soluble in DMSO, Synonyms: 2-(4-benzoylphenoxy)-N-(1-benzylpiperidin-4-yl)acetamide, Size: 10 mg

Glycogen Phosphorylase Inhibitor 1 mg. Glycogen Phosphorylase Inhibitor, Formula: C17H15ClF2N4O4, Molecular Weight: 412.8, Cas No: 648926-15-2, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: 1-(3-(3-(2-Chloro-4,5-difluorobenzoyl)ureido)-4-methoxyphenyl)-3-methylurea, Size: 1 mg

Glycogen Phosphorylase Inhibitor 5 mg. Glycogen Phosphorylase Inhibitor, Formula: C17H15ClF2N4O4, Molecular Weight: 412.8, Cas No: 648926-15-2, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: 1-(3-(3-(2-Chloro-4,5-difluorobenzoyl)ureido)-4-methoxyphenyl)-3-methylurea, Size: 5 mg

Pdgf Receptor Tyrosine Kinase Inhibitor 5 mg. Pdgf Receptor Tyrosine Kinase Inhibitor, Formula: C18H16FN3O2, MW: 325.3, Cas No: 627518-40-5, Purity: /= 99%, Appearance: White powder solid, Synonyms: 3-Fluoro-N-(6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamine, JNJ-10198409, Size: 5 mg

Pd 173074 5 mg. Pd 173074, Formula: C28H41N7O3, Molecular Weight: 523.7, Cas No: 219580-11-7, Purity: /= 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: 1-t-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)-pyrido[2,3-d]pyrimidin-7-yl)urea, Size: 5 mg

Pd 173074 10 mg. Pd 173074, Formula: C28H41N7O3, MW: 523.7, Cas No: 219580-11-7, Purity: /= 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: 1-t-Butyl-3-(6-(3,5-dimethoxyphenyl)-2-(4-diethylaminobutylamino)-pyrido[2,3-d]pyrimidin-7-yl)urea, Size: 10 mg

Sb 590885. Dihydrochloride 5mg. Sb 590885. Dihydrochloride, Formula: C27H27N5O2. HCl, Molecular Weight: 539, Cas No: 405554-55-4, Purity: /= 98% (HPLC), Appearance: Yellow powder solid, Synonyms: N,N-dimethyl-2-[4-[(4E)-4-(1-nitroso-2,3-dihydroinden-5-ylidene)-5-(1H-pyridin-4-ylidene)-1, Size: 5mg

Sb 590885. Dihydrochloride 10 mg. Sb 590885. Dihydrochloride, Formula: C27H27N5O2. HCl, MW: 539, Cas No: 405554-55-4, Purity: /= 98% (HPLC), Appearance: Yellow powder solid, Synonyms: N,N-dimethyl-2-[4-[(4E)-4-(1-nitroso-2,3-dihydroinden-5-ylidene)-5-(1H-pyridin-4-ylidene)-1, Size: 10 mg

Secinh3 5 mg. Secinh3, Formula: C24H20N4O4S, Molecular Weight: 460.5, Cas No: 853625-60-2, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: N-(4-(5-(1,3-Benzodioxol-5-yl)-3-methoxy-1H-1,2,4-triazol-1-yl)phenyl)-2-(phenylthio)acetamide, Cytohesin inhibitor I, Size: 5 mg

Chk2 Inhibitor 1 mg. Chk2 Inhibitor, Formula: C15H13N5O2, MW: 295.3, Cas No: 724708-21-8, Purity: /= 97% (HPLC), Appearance: Yellow powder solid, Synonyms: 5-(2-Amino-5-oxo-1,5-dihydroimidazol-4-ylidine)-3,4,5,10-2H-azepino[3,4-b]indol-1-one, Chk1 inhibitor II, Chk2 inhibitor I, Size: 1 mg

ABT-888 PARP inhibitor inhibitor 25 mg. ABT-888 PARP inhibitor inhibitor, Formula: C13H16N4O. 2HCl, MW: 244.3. 73.0, Cas No: 912445-05-7, Purity: /= 98%, Appearance:Colorless to white crystalline solid, Synonyms: 2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide, Size: 25 mg

KS-176BCRP inhibitor 2 mg. KS-176BCRP inhibitor, Formula: C22H19N3O5, Molecular Weight: 405.4, dependent transactivation of p53-responsive genes, Purity: /= 98%, Appearance: Pale yellow solid, Synonyms: N-(4-(2-hydroxyethyl)phenyl)-2-(4-nitrobenzamido)benzamide, Storage: -20 deg C, Size: 2 mg

PROTEOSTAT® Protein Aggregation Assay, Enzo Life Sciences - 51023-KP050, 50 Tests

PROTEOSTAT PDI assay inhibitor 50 tests. PROTEOSTAT PDI assay inhibitor, provides a simple, homogenous assay for screening modulators of PDI enzymatic activity, accomplished by monitoring PDI-catalyzed, Synonyms: Protein disulfide isomerase, Application: Fluorescent detection, Size: 50 tests

PROTEOSTAT Thermal shift stability assay kit 100 tests. PROTEOSTAT Thermal shift stability assay kit, Contains: TS Detection Reagent B-Lactoglobulin control10X Assay Buffersimple, sensitive, homogenous fluorescence assay with no need for sample separation or dilution, Size: 100 tests

27-Hydroxycholesterol 1 mg. 27-Hydroxycholesterol, Formula: C27H46O2, Molecular Weight: 402.7, Cas No: 20380-11-4, Purity: greater than or equal to 98% (HPLC), Appearance: White solid, Solubility: Soluble in DMSO, Synonyms: 5,25R-GCholestGen-G3B,G26-Gdiol, (25R)-26-Hydroxycholesterol, Size: 1 mg

27-Hydroxycholesterol 5 mg. 27-Hydroxycholesterol, Formula: C27H46O2, Molecular Weight: 402.7, Cas No: 20380-11-4, Purity: greater than or equal to 98% (HPLC), Appearance: White solid, Solubility: Soluble in DMSO, Synonyms: 5,25R-GCholestGen-G3B,G26-Gdiol, (25R)-26-Hydroxycholesterol, Size: 5 mg

Aflatoxicol 1 mg. Aflatoxicol, Mycotoxin, Metabolite of AflatoxinFormula: C17H14O6, Molecular Weight: 314.3, Cas No: 29611-03-8 RTECS: GY1934000, Purity: greater than or equal to 95% (HPLC), Appearance: White powder, Solubility: Soluble in DMSO, Synonyms: Aflatoxin R0, Size: 1 mg

Virginiamycin M1 5 mg. Virginiamycin M1, Streptogramin antibiotic, Source: Isolated from Streptomyces virginiae, Formula: C28H35N3O7, Molecular Weight: 525.6, Cas No: 21411-53-0, Purity: /= 95% (HPLC), Appearance: White solid, Synonyms: Mikamycin A, Staphilomycin, Ostreogrycin A, Size: 5 mg

Virginiamycin S1 5 mg. Virginiamycin S1, Streptogramin antibiotic, Source: Isolated from Streptomyces virginiae, Formula: C43H49N7O10, Molecular Weight: 823.9, Cas No: 23152-29-6, Purity: greater than or equal to 99% (HPLC), Appearance: White solid, Synonyms: Staphilomycin S, Size: 5 mg

Bisidolylmaleimide I. Hydrochloride 1 mg. Bisidolylmaleimide I. Hydrochloride, Formula: C25H24N4O2. 2 HCl, MW: 453.5, Cas No: 176504-36-2, Purity: /= 99%, Appearance: Orange crystalline solid, Synonyms: 3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide hydrochloride, Size: 1 mg

Bisidolylmaleimide I. Hydrochloride 5 mg. Bisidolylmaleimide I. Hydrochloride, Formula: C25H24N4O2. 2 HCl, MW: 453.5, Cas No: 176504-36-2, Purity: /= 99%, Appearance: Orange crystalline solid, Synonyms: 3-[1-(Dimethylaminopropyl)indol-3-yl]-4-(indol-3-yl)maleimide hydrochloride, Size: 5 mg

Chk2 Inhibitor 500 ug. Chk2 Inhibitor, Formula: C15H13N5O2, MW: 295.3, Cas No: 724708-21-8, Purity: /= 97%, Appearance: Yellow powder solid, Synonyms: 5-(2-Amino-5-oxo-1,5-dihydroimidazol-4-ylidine)-3,4,5,10-2H-azepino[3,4-b]indol-1-one, Chk1 inhibitor II, Chk2 inhibitor I, Size: 500 ug

Rac1 Inhibitor 5 mg. Rac1 Inhibitor, Formula: C24H35N7. 3 HCl, MW: 531, Cas No: 733767-34-5, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride, Size: 5 mg

Rac1 Inhibitor 10mg. Rac1 Inhibitor, Formula: C24H35N7. 3 HCl, MW: 531, Cas No: 733767-34-5, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: N6-[2-[[4-(Diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-quinolinediamine trihydrochloride, Size: 10mg

Ns 1738 10 mg. Ns 1738, Formula: C14H9Cl2F3N2O2, Molecular Weight: 365.1, Cas No: 501684-93-1, Purity: /= 99% (HPLC), Appearance: White crystalline solid, Synonyms: 1-(5-chloro-2-hydroxyphenyl)-3-(2-chloro-5-(trifluoromethyl)phenyl)urea, A7 nAChR positive allosteric modulator, Size: 10 mg

Ns 1738 50 mg. Ns 1738, Formula: C14H9Cl2F3N2O2, Molecular Weight: 365.1, Cas No: 501684-93-1, Purity: /= 99% (HPLC), Appearance: White crystalline solid, Synonyms: 1-(5-chloro-2-hydroxyphenyl)-3-(2-chloro-5-(trifluoromethyl)phenyl)urea, A7 nAChR positive allosteric modulator, Size: 50 mg

Fabp4 Inhibitor 5mg. Fabp4 Inhibitor, Formula: C31H26N2O3, MW: 474.6, Cas No: 300657-03-8, Purity: /= 99%, Appearance: White powder solid, Synonym: Adipocyte fatty-acid-binding protein inhibitor, ((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)(1,1'-biphenyl)-3-yl)oxy)-acetic acid, BMS 309403, Size: 5mg

Tnf-Inhibitor 1 mg. Tnf-+ Inhibitor, Formula: C32H32F3N3O2. 2 HCl, MW: 629.5, Cas No: 1049741-03-8, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: 6,7-Dimethyl-3-((methyl-(2-(methyl-(1-(3-trifluoromethyl-phenyl)-1H-indol-3-ylmethyl)-amino)-ethyl)-amino)-methyl), Size: 1 mg

Tnf-Inhibitor 5 mg. Tnf-+ Inhibitor, Formula: C32H32F3N3O2. 2 HCl, MW: 629.5, Cas No: 1049741-03-8, Purity: /= 99% (HPLC), Appearance: White powder solid, Synonyms: 6,7-Dimethyl-3-((methyl-(2-(methyl-(1-(3-trifluoromethyl-phenyl)-1H-indol-3-ylmethyl)-amino)-ethyl)-amino)-methyl), Size: 5 mg

Sant-1 1 mg. Sant-1, Formula: C23H27N5, MW: 373.5, Cas No: 304909-07-7, Purity: /= 99% (HPLC), Appearance: White crystalline solid, Solubility: Soluble in DMSO, Synonyms: Shh signaling antagonist V, (E)-N-(4-benzylpiperazin-1-yl)-1-(3,5-dimethyl-1-phenylpyrazol-4-yl)methanimine, Size: 1 mg

Mif Antagonist 5mg. Mif Antagonist, Formula: C12H13NO4, MW: 235.2, Cas No: 478336-92-4, Purity: /= 97%, Appearance: Light yellow crystalline solid, Synonym: (S,R)-3-(4-Hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester, Macrophage migration inhibitory antagonist, ISO-1, Size: 5mg

C5A Receptor Antagonist W-54011 1 mg. C5A Receptor Antagonist W-54011, Formula: C30H36N2O2. HCl, MW: 493.1, Cas No: 405098-33-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: N-((4-Dimethylaminophenyl)methyl)-N-(4-isopropylphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-, Size: 1 mg

C5A Receptor Antagonist W-54011 5 mg. C5A Receptor Antagonist W-54011, Formula: C30H36N2O2. HCl, MW: 493.1, Cas No: 405098-33-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: N-((4-Dimethylaminophenyl)methyl)-N-(4-isopropylphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-, Size: 5 mg

Mmp-13 Inhibitor 1 mg. Mmp-13 Inhibitor, Formula: C22H20F2N4O2, MW: 410.4, Cas No: 544678-85-5, Purity: /= 99%, Appearance: Light yellow crystalline solid, Synonyms: PB4, N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide, Pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro), Size: 1 mg

Mmp-13 Inhibitor 5 mg. Mmp-13 Inhibitor, Formula: C22H20F2N4O2, MW: 410.4, Cas No: 544678-85-5, Purity: /= 99%, Appearance: Light yellow crystalline solid, Synonyms: PB4, N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide, Pyrimidine-4,6-dicarboxylic acid, bis-(4-fluoro), Size: 5 mg

Gsk-3 Inhibitor Xiii 1 mg. Gsk-3 Inhibitor Xiii, Formula: C18H15N5, Molecular Weight: 301.4, Cas No: 404828-08-6, Purity: /= 99% (HPLC), Appearance: White crystalline solid, Solubility: Soluble in DMSO, Synonyms: (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine, Size: 1 mg

Gsk-3 Inhibitor Xiii 5 mg. Gsk-3 Inhibitor Xiii, Formula: C18H15N5, Molecular Weight: 301.4, Cas No: 404828-08-6, Purity: /= 99% (HPLC), Appearance: White crystalline solid, Solubility: Soluble in DMSO, Synonyms: (5-Methyl-1H-pyrazol-3-yl)-(2-phenylquinazolin-4-yl)amine, Size: 5 mg

Akt Inhibitor Viii 1 mg. Akt Inhibitor Viii, Formula: C34H29N7O, MW: 551.6, Cas No: 612847-09-3, Purity: /= 98%, Appearance: Yellow powder solid, Synonyms: Isozyme-selective Akt inhibitor VIII, 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl), Size: 1 mg

Akt Inhibitor Viii 5 mg. Akt Inhibitor Viii, Formula: C34H29N7O, MW: 551.6, Cas No: 612847-09-3, Purity: /= 98%, Appearance: Yellow powder solid, Synonyms: Isozyme-selective Akt inhibitor VIII, 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl), Size: 5 mg

10-Debc. Hydrochloride 1 mg. 10-Debc. Hydrochloride, Formula: C20H25ClN2O. HCl, Molecular Weight: 381.4, Cas No: 201788-90-1, Purity: /= 98% (HPLC), Appearance: White crystalline solid, Synonyms: 10-(4GC|-(N-diethylamino)butyl)-2-chlorophenoxazine. HCl, Akt inhibitor X, Size: 1 mg

Glucagon Receptor Antagonist I 1 mg. Glucagon Receptor Antagonist I, Formula: C20H30N2OS, MW: 346.5, Cas No: 438618-32-7, Purity: /= 99%, Appearance: White crystalline solid, Synonyms: N-[3-cyano-6-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-2-ethylbutanamide, Size: 1 mg

Glucagon Receptor Antagonist I 5 mg. Glucagon Receptor Antagonist I, Formula: C20H30N2OS, MW: 346.5, Cas No: 438618-32-7, Purity: /= 99%, Appearance: White crystalline solid, Synonyms: N-[3-cyano-6-(2-methylbutan-2-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-2-ethylbutanamide, Size: 5 mg

Syk Inhibitor 5mg. Syk Inhibitor, Formula: C18H15N3O3S, MW: 353.4, Cas No: 622387-85-3, Purity: /= 97% (HPLC), Appearance: Orange powder solid, Synonyms: Spleen tyrosine kinase inhibitor, 3-(1-Methyl-1H-indol-3-yl-methylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide, K00564a, Size: 5mg

Jk 184 5 mg. Jk 184, Formula: C19H18N4OS, Molecular Weight: 350.4, Cas No: 315703-52-7, Purity: /= 99% (HPLC), Appearance: Pink powder solid, Solubility: Soluble in DMSO, Synonyms: N-(4-ethoxyphenyl)-4-(2-methylimidazo[1,2-a]pyridin-3-yl)-1,3-thiazol-2-amine, Hh signaling antagonist VII, Size: 5 mg

Gdc-0941 10 mg. Gdc-0941, Formula: C23H27N7O3S2, MW: 513.6, Cas No: 957054-30-7, Purity: /= 99%, Appearance: White powder solid, Synonyms: PI 3-K inhibitor XXI, 2-(1H-Indazol-4-yl)-6-(4-methylsulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d]pyrimidine, 4-(2-(1H-Indazol), Size: 10 mg

Gdc-0941 50 mg. Gdc-0941, Formula: C23H27N7O3S2, MW: 513.6, Cas No: 957054-30-7, Purity: /= 99%, Appearance: White powder solid, Synonyms: PI 3-K inhibitor XXI, 2-(1H-Indazol-4-yl)-6-(4-methylsulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2- d]pyrimidine, 4-(2-(1H-Indazol), Size: 50 mg

Cdk/Crk Inhibitor 1 mg. Cdk/Crk Inhibitor, Formula: C23H22Cl2N4O3, MW: 473.4, Cas No: 784211-09-2, Purity: /= 98%, Appearance: White powder solid, Synonyms: 1-(2,6-Dichlorophenyl)-1,5-dihydro-6-((4-(2-hydroxyethoxy)phenyl)methyl)-3-(1-methylethyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one, Size: 1 mg

Pp242. Hydrate 1 mg. Pp242. Hydrate, Formula: C16H16N6O. H2O, MW: 326.3, Cas No: 1092351-67-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: 1-(2,6-Dichlorophenyl)-1,5-dihydro-6-((4-(2-hydroxyethoxy)phenyl)methyl)-3-(1-methylethyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one, Size: 1 mg

Pp242. Hydrate 5 mg. Pp242. Hydrate, Formula: C16H16N6O. H2O, MW: 326.3, Cas No: 1092351-67-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: 1-(2,6-Dichlorophenyl)-1,5-dihydro-6-((4-(2-hydroxyethoxy)phenyl)methyl)-3-(1-methylethyl)-4H-pyrazolo[3,4-d]pyrimidin-4-one, Size: 5 mg

Mmp-G9 Inhibitor I 1 mg. Mmp-G9 Inhibitor I, Formula: C27H33N3O5S, Molecular Weight: 511.6, Cas No: 1177749-58-4, Purity: /= 97% (HPLC), Appearance: White powder solid, Synonyms: 2-(N-benzyl-4-methoxyphenylsulfonamido)-5-((diethylamino)methyl)-N-hydroxy-3-methylbenzamide, Size: 1 mg

Gsk-3Inhibitor Xviii 5 mg. Gsk-3+ Inhibitor Xviii, Formula: C20H20ClN5OS, Molecular Weight: 413.9, Cas No: 1139875-74-3, Purity: /= 98% (HPLC), Appearance: White powder solid, Synonyms: 2-(Chloro-4-(4-thiophen-2-yl-pyrimidin-2-ylamino)-phenyl)-(4-methyl-pierazin-1-yl)-methanone, Size: 5 mg

Ku-0063794 5 mg. Ku-0063794, Formula: C25H31N5O4, MW: 465.5, Cas No: 938440-64-3, Purity: /= 99%, Appearance: Yellow powder solid, Synonyms: rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol, mTOR Inhibitor IV, Size: 5 mg

Ku-0063794 10 mg. Ku-0063794, Formula: C25H31N5O4, MW: 465.5, Cas No: 938440-64-3, Purity: /= 99%, Appearance: Yellow powder solid, Synonyms: rel-5-[2-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-4-(4-morpholinyl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol, mTOR Inhibitor IV, Size: 10 mg

Mtor Inhibitor Wye-23 1mg. Mtor Inhibitor Wye-23, Formula: C26H32N8O4, MW: 520.6, Cas No: 1062169-46-3, Purity: /= 99%, Appearance: White powder solid, Synonym: 4-{6-[4-(3-Cyclopropyl-ureido)-phenyl]-4-morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl}-piperidine-1-carboxylic acid ester, Size: 1mg

Mtor Inhibitor Wye-23 5mg. Mtor Inhibitor Wye-23, Formula: C26H32N8O4, MW: 520.6, Cas No: 1062169-46-3, Purity: /= 99%, Appearance: White powder solid, Synonym: 4-{6-[4-(3-Cyclopropyl-ureido)-phenyl]-4-morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl}-piperidine-1-carboxylic acid methyl, Size: 5mg

Mtor Inhibitor Wye-28 1 mg. Mtor Inhibitor Wye-28, Formula: C30H34N8O5, MW: 586.6, Cas No: 1062172-60-4, Purity: /= 97%, Appearance: White powder solid, Synonyms: 4-(6-{4-[3-(4-Hydroxymethyl-phenyl)-ureido]-phenyl}-4-morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl)--1-carboxylic, Size: 1 mg

Mtor Inhibitor Wye-28 5 mg. Mtor Inhibitor Wye-28, Formula: C30H34N8O5, MW: 586.6, Cas No: 1062172-60-4, Purity: /= 97%, Appearance: White powder solid, Synonyms: 4-(6-{4-[3-(4-Hydroxymethyl-phenyl)-ureido]-phenyl}-4-morpholin-4-yl-pyrazolo[3,4-d]pyrimidin-1-yl)-piperidine-1-carboxylic, Size: 5 mg

Ic87114 5 mg. Ic87114, Formula: C22H19N7O, Molecular Weight: 397.4, Cas No: 371242-69-2, Purity: greater than or equal to 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: Phosphatidylinositol 3-kinase p110d inhibitor, PI 3-K inhibitor X, Size: 5 mg

Ic87114 10 mg. Ic87114, Formula: C22H19N7O, Molecular Weight: 397.4, Cas No: 371242-69-2, Purity: greater than or equal to 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: Phosphatidylinositol 3-kinase p110d inhibitor, PI 3-K inhibitor X, Size: 10 mg

Tg100-115 5 mg. Tg100-115, Formula: C18H14N6O2, Molecular Weight: 346.3, Cas No: 677297-51-7, Purity: greater than or equal to 98% (HPLC), Appearance: Yellow powder solid, Solubility: Soluble in DMSO, Synonyms: 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine, Size: 5 mg

Tg100-115 10 mg. Tg100-115, Formula: C18H14N6O2, Molecular Weight: 346.3, Cas No: 677297-51-7, Purity: greater than or equal to 98% (HPLC), Appearance: Yellow powder solid, Solubility: Soluble in DMSO, Synonyms: 6,7-Bis(3-hydroxyphenyl)pteridine-2,4-diamine, Size: 10 mg

Mtor Inhibitor Wye-132 1 mg. Mtor Inhibitor Wye-132, Formula: C27H33N7O4, MW: 519.6, Cas No: 1144068-46-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: 1-{4-[1-(1,4-Dioxa-spiro[4.5]dec-8-yl)-4-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-phenyl}, Size: 1 mg

Mtor Inhibitor Wye-132 5 mg. Mtor Inhibitor Wye-132, Formula: C27H33N7O4, MW: 519.6, Cas No: 1144068-46-1, Purity: /= 99%, Appearance: White powder solid, Synonyms: 1-{4-[1-(1,4-Dioxa-spiro[4.5]dec-8-yl)-4-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl]-phenyl}-3, Size: 5 mg

Dorsomorphin. Hydrochloride 5 mg. Dorsomorphin. Hydrochloride, Formula: C24H25N5O. 2 HCl, MW: 472.4, Cas No: 1219168-18-9, Purity: /= 99%, Appearance: Light yellow powder solid, Synonyms: 6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-pyrazolo[1,5-a]pyrimidine dihydrochloride, Size: 5 mg

Dorsomorphin. Hydrochloride 10 mg. Dorsomorphin. Hydrochloride, Formula: C24H25N5O. 2 HCl, MW: 472.4, Cas No: 1219168-18-9, Purity: /= 99%, Appearance: Light yellow powder solid, Synonyms: 6-[4-[2-(1-Piperidinyl)ethoxy]phenyl]-3-(4-pyridinyl)-pyrazolo[1,5-a]pyrimidine dihydrochloride, Size: 10 mg

Simvastatin. Sodium Salt 5mg. Simvastatin. Sodium Salt, Formula: C25H39O6. Na, MW: 458.6, Cas No: 101314-97-0, Purity: /= 97%, Appearance: White powder solid, Synonym: (BR,G delta R,G1S,G2S,G6R,G8S,G8aR)-G8-G(2,G2-Gdimethyl-G1-Goxobutoxy)-G1,G2,G6,G7,G8,G8a-Ghexahydro-GB,G delta, Size: 5mg

Simvastatin. Sodium Salt 10mg. Simvastatin. Sodium Salt, Formula: C25H39O6. Na, MW: 458.6, Cas No: 101314-97-0, Purity: /= 97%, Appearance: White powder solid, Synonym: (BR,G delta R,G1S,G2S,G6R,G8S,G8aR)-G8-G(2,G2-Gdimethyl-G1-Goxobutoxy)-G1,G2,G6,G7,G8,G8a-Ghexahydro-GB,G delta G2, Size: 10mg

Nsc697923 5 mg. Nsc697923, Formula: C11H9NO5S, Molecular Weight: 267.3, Cas No: 343351-67-7, Purity: greater than or equal to 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: 2-[(4-Methylphenyl)sulfonyl]-5-nitro-furan, 2-Nitro-5-tosylfuran, Size: 5 mg

Wh-4-023 5 mg. Wh-4-023, Formula: C32H36N6O4, Molecular Weight: 568.7, Cas No: 837422-57-8, Purity: /= 99% (HPLC), Appearance: Beige powder solid, Synonyms: 2,6-Dimethylphenyl-N-(2,4-dimethoxyphenyl)-N-[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]carbamate, Size: 5 mg

Wh-4-023 10 mg. Wh-4-023, Formula: C32H36N6O4, Molecular Weight: 568.7, Cas No: 837422-57-8, Purity: /= 99% (HPLC), Appearance: Beige powder solid, Synonyms: 2,6-Dimethylphenyl-N-(2,4-dimethoxyphenyl)-N-[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]carbamate, Size: 10 mg

Agk7 5 mg. Agk7, Selectively inhibits sirtuin 3 over sirtuins 1 and 2, Formula: C23H13Cl2N3O2, Molecular Weight: 434.3, Cas No: 304896-21-7, Purity: /= 99% (HPLC), Appearance: Yellow powder solid, Solubility: Soluble in DMSO, Synonyms: SIRT2 inhibitor (inactive control), Size: 5 mg

Agk7 10 mg. Agk7, Formula: C23H13Cl2N3O2, Molecular Weight: 434.3, Cas No: 304896-21-7, Purity: greater than or equal to 99% (HPLC), Appearance: Yellow powder solid, Solubility: Soluble in DMSO, Synonyms: SIRT2 inhibitor (inactive control), Size: 10 mg

Motesanib 1 mg. Motesanib, Cell-permeable inhibitor of VEGF receptors, PDGFR, and Kit receptor, Formula: C22H23N5O, Molecular Weight: 373.5, Cas No: 453562-69-1, Purity: greater than or equal to 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: AMG-706, Size: 1 mg

Motesanib 5 mg. Motesanib, Cell-permeable inhibitor of VEGF receptors, PDGFR, and Kit receptor, Formula: C22H23N5O, Molecular Weight: 373.5, Cas No: 453562-69-1, Purity: greater than or equal to 99% (HPLC), Appearance: White powder solid, Solubility: Soluble in DMSO, Synonyms: AMG-706, Size: 5 mg

Ku55933 5 mg. Ku55933, Formula: C21H17NO3S2, Molecular Weight: 395.5, Cas No: 587871-26-9, Purity: greater than or equal to 99% (HPLC), Appearance: Beige powder, Solubility: Soluble in DMSO, Synonyms: ATM kinase inhibitor, 2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one, Size: 5 mg

Ku55933 10 mg. Ku55933, Formula: C21H17NO3S2, Molecular Weight: 395.5, Cas No: 587871-26-9, Purity: greater than or equal to 99% (HPLC), Appearance: Beige powder, Solubility: Soluble in DMSO, Synonyms: ATM kinase inhibitor, 2-Morpholino-6-(thianthren-1-yl)-4H-pyran-4-one, Size: 10 mg

Erlotinib. Hcl 50 mg. Erlotinib. Hcl, Formula: C22H23N3O4. HCl, Molecular Weight: 429.9, Cas No: 183319-69-9, Purity: greater than or equal to 95% (HPLC), Appearance: Yellow powder, Solubility: Soluble in DMSO, Synonyms: OSI774, CP-358774, NSC718781, Size: 50 mg

(R)-Bi-2536 5 mg. (R)-Bi-2536, Potent and selective inhibitor of mammalian Plk1, Formula: C28H39N7O3, Molecular Weight: 521.7, Cas No: 755038-02-9, Purity: greater than or equal to 97% (HPLC), Appearance: Yellow powder, Solubility: Soluble in DMSO, Size: 5 mg

Category